baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UBS Call 164 JNJ 17.01.2025/ CH1304630184 /

1/10/2025 8:55:14 AM	Chg.0.000	Bid10:05:52 AM	Ask10:05:52 AM	Underlying	Strike price	Expiration date	Option type
0.001EUR	0.00%	0.001 Bid Size: 7,500	- Ask Size: -	Johnson and Johnson	164.00 USD	1/17/2025	Call

TeleTrader 1/2 J&J announces dividend for Q1 2025

TeleTrader 10/15/2024 J&J's Q3 sales rise by 5.2% to $22.5B

TeleTrader 10/1/2024 J&J: Over $2B to be put into new facility in North Carolina

TeleTrader 9/10/2024 D. S. Davis retires as director of Johnson & Johnson

TeleTrader 8/20/2024 Johnson & Johnson to buy V-Wave for up to $1.7B

GlobeNewswire 8/14/2024 BlueSphere Bio Accepted as Member of Johnson & Johnson Innovation-JLABS

TeleTrader 7/17/2024 J&J's Q2 sales up by 4.3% to $22.4 billion

GlobeNewswire 5/28/2024 Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey ...

TeleTrader 5/1/2024 J&J to pay $6.5 billion to settle US talc-related lawsuits

GlobeNewswire 4/17/2024 TRC Amends Its Tender Offer for Johnson & Johnson

GlobeNewswire 4/10/2024 SWAV Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Shockwave Medical t...

TeleTrader 4/5/2024 J&J to acquire Shockwave Medical for $13.1B

TeleTrader 3/26/2024 J&J may allegedly acquire Shockwave Medical

GlobeNewswire 3/15/2024 CURE Media Group and Oncology Nursing News Announces the 2024 Extraordinary Healer® Award Finalists

GlobeNewswire 3/6/2024 Ambrx Shareholders Approve Acquisition by Johnson & Johnson

TeleTrader 1/27/2024 J&J, Merck CEOs to testify before Senate on drug prices

TeleTrader 1/24/2024 J&J to pay $149.5M to settle Washington state opioid case

TeleTrader 1/23/2024 J&J to pay $700M in talc powder probe settlement

TeleTrader 1/23/2024 J&J's Q4 sales top estimates, up 7.3% to $21.4B

TeleTrader 1/23/2024 Johnson & Johnson Q4 earnings preview

TeleTrader 1/22/2024 Earnings preview: Tesla takes center stage

TeleTrader 1/8/2024 J&J to buy biotech company Ambrx for $2B

GlobeNewswire 12/4/2023 Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovat...

TeleTrader 11/7/2023 J&J to begin trials with surgical robot

UBS Call 164 JNJ 17.01.2025/ CH1304630184 /

If you wish to receive reply to your feedback, please provide your email address.